TsuyukiRTSemchukWPoirierL; for the Canadian Hypertension Education Program. 2006 Canadian Hypertension Guidelines for the management of hypertension by pharmacists. Can Pharm J2006;139 (Suppl 1):S11–S13
2.
PadwalRSHemmelgarnBRMcAlisterFA; for the Canadian Hypertension Education Program. The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1 — blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol2007;23:529–38
3.
KhanNABemmelgarnBPadwalR, for the Canadian Hypertension Education Program. The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 — therapy. Can J Cardiol2007;23:539–50
4.
TsuyukiRTJohnsonJATeoKKA randomized trial of the effect of community pharmacist intervention on cholesterol risk: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med.2002;162:1149–55
5.
SemchukWTaylorJSulzLPharmacist Intervention in Risk Reduction study: high-risk cardiac patients. Can Pharm J2007;140 (1):32–7
6.
TsuyukiRTOlsonKLDubykAMEffect of community pharmacist intervention on cholesterol levels in patients with high risk of cardiovascular events: the second Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP-plus). Am J Med.2004;116:130–3
